Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CVS HEALTH CORPORATION

(CVS)
  Report
Delayed Nyse  -  04:00 2022-12-09 pm EST
101.65 USD   -0.86%
12/08Aetna provides $6.1 million to support services for Children with Serious Emotional Disorders
PR
12/07Around 5.5 million people have signed up for 2023 Obamacare plans
RE
12/05MarketScreener's World Press Review: December 5, 2022
MS
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/05/2022 12/06/2022 12/07/2022 12/08/2022 12/09/2022 Date
102.01(c) 101.19(c) 102.28(c) 102.53(c) 101.65 Last
3 645 333 4 060 205 4 824 540 4 063 563 4 383 004 Volume
-0.56% -0.80% +1.08% +0.24% -0.86% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 314 B - -
Net income 2022 4 371 M - -
Net Debt 2022 40 593 M - -
P/E ratio 2022 33,2x
Yield 2022 2,14%
Sales 2023 325 B - -
Net income 2023 10 048 M - -
Net Debt 2023 34 252 M - -
P/E ratio 2023 13,4x
Yield 2023 2,23%
Capitalization 134 B 134 B -
EV / Sales 2022 0,55x
EV / Sales 2023 0,52x
Nbr of Employees 258 000
Free-Float 74,5%
More Financials
Company
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.5%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information... 
More about the company
Ratings of CVS Health Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about CVS HEALTH CORPORATION
12/08Aetna provides $6.1 million to support services for Children with Serious Emotional Dis..
PR
12/07Around 5.5 million people have signed up for 2023 Obamacare plans
RE
12/05MarketScreener's World Press Review: December 5, 202..
MS
12/05CVS Reportedly Testing Remote Prescription System
MT
12/05North American Morning Briefing: Fed Tightening Fears to..
DJ
12/02bswift appoints Ted Bloomberg as New Chief Executive Officer
AQ
12/01CVS Health Opens MinuteClinic Locations in Delaware
PR
12/01CVS Health Opens Minuteclinic Locations in Delaware
CI
11/30Cvs Health : completes rollout of time delay safes in 13 states
PU
11/28North American Morning Briefing: Covid Protests in China Spread, Hit Market Se..
DJ
11/23Morgan Stanley Adjusts Price Target on CVS Health to $119 From $124, Assumes Overweight..
MT
11/22Factbox-Pharmacies, drug companies settle lawsuits over U.S. opioid crisis
RE
11/21CVS Health Approves $10 Billion Share Repurchase Program
MT
11/21Cvs Health Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other E..
AQ
11/21Credit Suisse Raises CVS Health's Price Target to $125 From $117, Keeps Outperform Rati..
MT
More news
News in other languages on CVS HEALTH CORPORATION
12/05CVS HEALTH : une technologie pour traiter les ordonnances à distance
12/05Cronache di Borsa - Lunedì 5 dicembre
12/05CVS testerait un système d'ordonnances à distance
12/054 minutos de mercados del lunes 5 de diciembre
12/05Départ chez Vodafone, BYD au Japon, BP sur l'hydrog..
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
ETFs positioned on CVS HEALTH CORPORATIONETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Invesco S&P 500 Enhanced Value ETF - USD5.2%-3.73%United_States
Global Beta Low Beta ETF - USD5.02%-0.85%-NC
VanEck Vectors Retail ETF - USD4.71%-2.17%United_States
Nomura NEXT FUNDS International Equity MSCI...3.92%-3.33%-World
UBS (Irl) ETF plc - Factor MSCI USA Prime V...3.82%-0.61%United_States
More ETFs positioned on CVS HEALTH CORPORATION
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 101,65 $
Average target price 118,40 $
Spread / Average Target 16,5%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
Roger N. Farah Chairman
Sreekanth Chaguturu Chief Medical Officer & Executive Vice President
Tilak Mandadi EVP, Chief Data, Digital & Technology Officer